Gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) are fairly rare neoplasms that present many clinical challenges. They secrete peptides and neuroamines that cause distinct clinical syndromes, including carcinoid syndrome. However, many are clinically silent until late presentation with mass effects. Investigation and management should be highly individualised for a patient, taking into consideration the likely natural history of the tumour and general health of the patient. Manageme...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Gastroenteropancreatic neuroendocrine tumours.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record